Mission and Goals
The Mucositis Study Group’s major goal is to improve outcomes of patients experiencing oral and gastrointestinal mucositis associated with anticancer therapies. This study group works closely with the International Society of Oral Oncology (ISOO). Our objectives are to improve the design and conduct of clinical investigations, disseminate up-to-date educational information regarding mucositis, and serve as a resource for investigators in basic science, clinical, and health services research, as well as for industrial collaborators, clinicians, and patients.
Evidence-based clinical practice guidelines created by the Mucositis Study Group
Recent scientific publications from the Mucositis Study Group
Gastrointestinal Complications of Immunotherapy and Targeted Agents Prevention and Treatment Options
Oral Complications of Immunotherapies and TKIs: Similarities and Differences to Conventional Oral Mucositis